Sebastian Lyon, manager of the £2.6bn Trojan fund, has been selling out of some of the "more predictable" businesses in the portfolio, as valuations have soared.
At the end of October, Lyon (pictured) reduced his holdings in Altria, Dr Pepper and Reynolds American, which have all performed strongly this year. For example, Altria is up 15.8% year to date, Dr Pepper is up 23.8%, while Reynolds American has risen 42.8% since the start of the year. "There is little room for error," the manager said. "For the more predictable businesses that we favour, valuations are now at ten-year highs in some cases. "Herding into 'safety' at record highs is not necessarily safe." Lyon pointed to the growing number of dividend cuts over the past year, with...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes